Healthcare -
Biotechnology - NASDAQ - US
$ 9.5
0.849 %
$ 968 M
Market Cap
-1.74
P/E
NTLA - CASH & EQUIVALENTS
Cash & Equivalents NTLA - Intellia Therapeutics, Inc.
227 M
LAST VALUE
35.55%
2 YEAR CAGR
30.96%
5 YEAR CAGR
0.00%
10 YEAR CAGR